Citations

Showing 10 of 108119 citations.

Post‐relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation
Zhao, Qiuhong , Qazilbash, Muzaffar H. , Patel, Krina K. , Narra, Ravi , Christian, Beth , Kharfan‐Dabaja, Mohamed A. , Epperla, Narendranath , Epperla, Narendranath , Ahmed, Sairah , Hanel, Walter G. , Kansagra, Ankit , Iqbal, Madiha , Awan, Farrukh T. , Jaglowski, Samantha , Hamadani, Mehdi

Mayo Clinic

Hematological Oncology | November 11, 2021 | Volume: 40 | Issue: 1 | Pages: 49-57

10.1002/hon.2946 | PMID 34763367 Get It

Abstract Waldenström macroglobulinemia (WM) is a rare B‐cell lymphoproliferative malignancy. Autologous hematopoietic cell transplantation (auto‐HCT) is considered in a subset of WM patients with relapsed disease. While registry data has shown a benefit for auto‐HCT in relapsed WM, there is a paucity of data on outcomes of patients relapsing after auto‐HCT. Eligibility criteria included adult patients with relapsed/refractory WM who underwent auto‐HCT between 2007 and 2017. The primary endpoint was post‐relapse overall survival (PR‐OS). Secondary endpoints were to identify factors prognostic of PR‐OS. Of the 48 patients with WM who underwent auto‐HCT, 22 (46%) experienced relapse following auto‐HCT. Median PR‐OS of relapsed WM patients after auto‐HCT ( n = 22) was not reached (NR) (95% confidence interval [CI]: 17.5 months‐NR). Among patients who relapsed <1 year versus ≥1 year from auto‐HCT, the median PR‐OS was 18.4 months (95%CI: 0.8‐NR) months and NR (95%CI: 17.5‐NR), respectively ( p = 0.06). Of note, disease status at the time of transplant, CR/VGPR versus partial remission did not appear to impact PR‐OS. The median PR‐OS was significantly longer in patients who received ibrutinib in the post‐transplant setting compared to those who did not (NR vs. 18.4 months, 95%CI: 9.1‐NR, p = 0.02). On univariable analysis, the presence of complex karyotype (RR = 4.87, 95% CI = 1.22–19.53) and a higher number of prior lines of therapy (RR = 1.81, 95% CI = 1.23–2.67) were associated with a significantly higher risk of relapse. This is the only study to date that evaluated outcomes of WM patients who relapsed following auto‐HCT and provides a benchmark for future trials evaluating survival following auto‐HCT relapse.
A Possible Role for Serum Thyroglobulin to Predict Structural Recurrence of Papillary Thyroid Cancer After Thyroid Lobectomy
Shah, Aashka , Maraka, Spyridoula

Mayo Clinic

Clinical Thyroidology | November 11, 2021 | Volume: 33 | Issue: 11 | Pages: 497-499

10.1089/ct.2021;33.497-499 Get It

Tumor Volume Doubling Time as a Disease Predictor for Tumor Growth and Lymph Node Metastasis in Papillary Thyroid Microcarcinoma
Henriquez, Andres F., Brito, Juan P.

Mayo Clinic

Clinical Thyroidology | November 11, 2021 | Volume: 33 | Issue: 11 | Pages: 490-492

10.1089/ct.2021;33.490-492 Get It

Association of Premenopausal Bilateral Oophorectomy With Cognitive Performance and Risk of Mild Cognitive Impairment
Rocca, Walter A. , Lohse, Christine M. , Fields, Julie A. , Smith, Carin Y. , Machulda, Mary M. , Mielke, Michelle M.

Mayo Clinic

JAMA Network Open | November 11, 2021 | Volume: 4 | Issue: 11 | Pages: e2131448

10.1001/jamanetworkopen.2021.31448 | PMID 34762113 Get It

Author response: The mitochondrial iron transporter ABCB7 is required for B cell development, proliferation, and class switch recombination in mice
Lehrke, Michael Jonathan , Shapiro, Michael J. , Rajcula, Matthew, Kennedy, Madeleine M, McCue, Shaylene , Medina, Kay L. , Shapiro, Michael Jeremy, Kennedy, Madeleine, Shapiro, Virginia Smith

Mayo Clinic

No container title available | November 11, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.69621.sa2 Get It

The temporal onset of the core features in dementia with Lewy bodies
Choudhury, Parichita , Graff‐Radford, Jonathan , Aakre, Jeremiah A. , Wurtz, Lincoln , Graff‐Radford, Neill R. , Kantarci, Kejal , Forsberg, Leah K. , Fields, Julie A. , Pedraza, Otto , Chen, Qin , Miyagawa, Toji , Day, Gregory S. , Tipton, Philip W. , Savica, Rodolfo , Lachner, Christian , Dredla, Brynn K., Reichard, R. Ross , Petersen, Ronald C. , Ferman, Tanis J. , Tipton, Philip, Dredla, Brynn, Tipton, Philip W , Kantarci, Kejal , Day, Gregory S , Ferman, Tanis J , Choudhury, Parichita , Knopman, David S. , Botha, Hugo , Dickson, Dennis W. , Boeve, Bradley F.

Mayo Clinic

Alzheimer's & Dementia | November 11, 2021 | Volume: 18 | Issue: 4 | Pages: 591-601

10.1002/alz.12411 | PMID 34761850 Get It

AbstractIntroductionWe examined the temporal sequence of the core features in probable dementia with Lewy bodies (DLB).MethodsIn 488 patients with probable DLB, the onset of each core feature and time to diagnosis was determined for men and women, and a pathologic subgroup (n = 209).ResultsREM sleep behavior disorder (RBD) developed before the other core features in men and women. Men were more likely to have RBD and were diagnosed with probable DLB earlier than women. Visual hallucinations developed after the other core features in men, but in women, they appeared earlier and concurrently with fluctuations and parkinsonism. Women were older and more cognitively impaired at first visit, were less likely to have RBD, more likely to be diagnosed with probable DLB later than men, and more likely to have neocortical tangles.DiscussionAn earlier latency to probable DLB was associated with men, RBD, and Lewy body disease without neocortical tangles.
Calcific Tendinosis Reduces Diagnostic Performance of Magnetic Resonance Imaging in the Detection of Rotator Cuff Tears
Sill, Andrew P., Zaw, Taryar, Flug, Jonathan A., Hartigan, David E., Kransdorf, Mark J., Brinkman, Joseph, Fox, Michael G., Sill, Andrew , Zaw, Taryar, Flug, Jonathan A., Hartigan, David E., Kransdorf, Mark J., Brinkman, Joseph, Fox, Michael G.

Mayo Clinic

Journal of Computer Assisted Tomography | November 11, 2021 | Volume: 46 | Issue: 2 | Pages: 219-223

10.1097/rct.0000000000001257 | PMID 35297578 Get It

Objective This study aimed to investigate the effect of calcific tendinosis on the diagnosis of rotator cuff tears (RCTs) on magnetic resonance imaging (MRI) and magnetic resonance arthrography (MRA). Materials and Methods Calcific tendinosis was confirmed radiographically. Two musculoskeletal radiologists then retrospectively and independently reviewed the MRI/MRA examinations, with surgery or arthroscopy performed within 90 days of the MRI. Rotator cuffs were categorized as no tear, partial-thickness tear, and full-thickness tear. Partial-thickness tear/full-thickness tear groups were combined for analysis. Results Forty-eight MRI (mean age, 63.4 years; range, 37–83 years; female-to-male ratio, 29:19) and 7 MRA (mean age, 49.2 years; range, 25–60 years; female-to-male ratio, 4:3) patients were included. Reader 1 and reader 2 sensitivity/specificity values for RCTs on MRI were 95%/50% and 89%/30%, and the values on MRA were 100%/67% and 100%/100%, respectively. Overall agreement was present in 87% (48 of 55; κ = 0.55 [95% confidence interval, 0.26–0.85]). Conclusions Magnetic resonance imaging has decreased specificity in diagnosing RCTs when calcific tendinosis is present. Magnetic resonance arthrography performed better in this population and could be considered.
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
Olsen, Elise A. , Whittaker, Sean , Willemze, Rein , Pinter‐Brown, Lauren , Foss, Francine M. , Schwartz, Lawrence , Guitart, Joan , Zic, John A., Wood, Gary S. , Ai, Wei , Gru, Alejandro A. , Guenova, Emmanuella , Hodak, Emmilia , Hoppe, Richard T. , Lechowicz, Mary Jo , Ortiz‐Romero, Pablo L. , Papadavid, Evangelia , Pittelkow, Mark R. , Prince, H. Miles , Sanches, José Antônio , Sugaya, Makoto , Vermeer, Maarten H. , Knobler, Robert , Stadler, Rudolf , Scarisbrick, Julia , Foss, Francine , Kim, Youn H , Gru, Alejandro , Guenova, Emmanuella , Ortiz-Romero, Pablo , Prince, H Miles , Sanches, Jose Antonio , Sugaya, Makoto , Vermeer, Maarten , Zain, Jasmine , Knobler, Robert , Stadler, Rudolf , Scarisbrick, Julia , Hoppe, Richard T , Geskin, Larisa J. , Horwitz, Sarah McCue , Duvic, Madeleine , Ai, Wei, Girardi, Michael , Kempf, Werner , Kim, Ellen , Quaglino, Pietro , Bagot, Martine

Mayo Clinic

Blood | November 11, 2021 | Volume: 140 | Issue: 5 | Pages: 419-437

10.1182/blood.2021012057 | PMID 34758074 Get It

Abstract The number of patients with primary cutaneous lymphoma (PCL) relative to other non-Hodgkin lymphomas (NHLs) is small and the number of subtypes large. Although clinical trial guidelines have been published for mycosis fungoides/Sézary syndrome, the most common type of PCL, none exist for the other PCLs. In addition, staging of the PCLs has been evolving based on new data on potential prognostic factors, diagnosis, and assessment methods of both skin and extracutaneous disease and a desire to align the latter with the Lugano guidelines for all NHLs. The International Society for Cutaneous Lymphomas (ISCL), the United States Cutaneous LymphomaConsortium (USCLC), and the Cutaneous Lymphoma Task Force of the European Organization for the Research and Treatment of Cancer (EORTC) now propose updated staging and guidelines for the study design, assessment, endpoints, and response criteria in clinical trials for all the PCLs in alignment with that of the Lugano guidelines. These recommendations provide standardized methodology that should facilitate planning and regulatory approval of new treatments for these lymphomas worldwide, encourage cooperative investigator-initiated trials, and help to assess the comparative efficacy of therapeutic agents tested across sites and studies.
A Less Costly “No Touch” Technique: Iodine-Impregnated Adhesive Surgical Drape
Pflibsen, Lacey R., Leach, Garrison A., Teven, Chad M., Bristyan, Meghan C., Holcombe, Travis C., Pflibsen, Lacey R., Leach, Garrison A., Teven, Chad M., Bristyan, Meghan C., Holcombe, Travis C.

Mayo Clinic

Plastic & Reconstructive Surgery | November 10, 2021 | Volume: 148 | Issue: 6 | Pages: 1082e-1084e

10.1097/prs.0000000000008532 | PMID 34758000 Get It

Sexual dimorphism in functional pain syndromes
Navratilova, Edita , Porreca, Frank , Porreca, Frank , Navratilova, Edita , Fillingim, Roger Benton

Mayo Clinic

Science Translational Medicine | November 10, 2021 | Volume: 13 | Issue: 619 | Pages: No page available

10.1126/scitranslmed.abj7180 | PMID 34757805 Get It

Sexual dimorphism in functional pain suggests the need of developing sex-specific therapies.